Status:

COMPLETED

To Evaluate Immunogenicity, Reactogenicity & Safety of 2 Doses of GSK Bio HRV Liquid Vaccine Given to Infants (Vietnam)

Lead Sponsor:

GlaxoSmithKline

Conditions:

Infections, Rotavirus

Eligibility:

All Genders

6-10 years

Phase:

PHASE3

Brief Summary

To provide specific data on immunogenicity of GSK Biologicals' HRV liquid vaccine, when co-administered with the routine Expanded Program of Immunization (EPI) in Vietnam. The study will also assess r...

Eligibility Criteria

Inclusion

  • Healthy male or female infant between, and including, 6 and 10 weeks of age with a birth weight of \> 2000 grams.
  • Written informed consent obtained from the parent or guardian of the subject.

Exclusion

  • Use of any investigational or non-registered product (drug or vaccine) other than the HRV liquid vaccine or placebo within 30 days preceding the first dose of HRV liquid vaccine or placebo, or planned use during the study period.
  • Chronic administration of immunosuppressants or other immune-modifying drugs since birth.
  • Planned administration/ administration of a vaccines not foreseen by the study protocol except for DTPw, HBV and OPV vaccines within 14 days before each dose of HRV liquid vaccine or placebo and ending 14 days after.
  • Concurrently participating in another clinical study, at any time during the study period, in which the subject has been or will be exposed to an investigational or a non-investigational product (pharmaceutical product or device).
  • History of allergic disease or reactions likely to be exacerbated by any component of the HRV liquid vaccine or placebo.

Key Trial Info

Start Date :

September 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2007

Estimated Enrollment :

375 Patients enrolled

Trial Details

Trial ID

NCT00345956

Start Date

September 1 2006

End Date

March 1 2007

Last Update

October 28 2016

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

GSK Investigational Site

Hanoi, Vietnam, 084

2

GSK Investigational Site

Nhatrang, Vietnam, 084